Sarcopenia Coexisting with High Adiposity Exacerbates Insulin Resistance and Dyslipidemia in Saudi Adult Men

References

• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation–mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012;32:1771–1776. doi:10.1161/ATVBAHA.111.241869
   PubMed Web of Science ®Google Scholar
• Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol. 2005;46:1978–1985. doi:10.1016/j.jacc.2005.06.082
   PubMed Web of Science ®Google Scholar
• Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403–414. doi:10.1016/j.jacc.2006.09.032
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:10.1016/j.jamda.2013.11.025
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, Wang Z, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 years. J Appl Physiol. 2000;89(1):81–88. doi:10.1152/jappl.2000.89.1.81
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889–896. doi:10.1046/j.1532-5415.2002.50216.x
   PubMed Web of Science ®Google Scholar
• Zhang H, Lin S, Gao T, et al. Association between sarcopenia and metabolic syndrome in middle-aged and older non-obese adults: a systematic review and meta-analysis. Nutrients. 2018;10:E364. doi:10.3390/nu10030364
   PubMedGoogle Scholar
• Yakout SM, Alkahtani SA, Al-Disi D, et al. Coexistence of pre-sarcopenia and metabolic syndrome in Arab men. Calcif Tissue Int. 2019;104:130–136. doi:10.1007/s00223-018-0477-2
   PubMedGoogle Scholar
• Alkahtani SA. A cross-sectional study on sarcopenia using different methods: reference values for healthy Saudi young men. BMC Musculoskelet Disord. 2017;18:119. doi:10.1186/s12891-017-1483-7
   PubMedGoogle Scholar
• Pietrobelli A, Rubiano F, St-Onge MP, Heymsfield SB. New bioimpedance analysis system: improved phenotyping with whole-body analysis. Eur J Clin Nutr. 2004;58:1479–1484. doi:10.1038/sj.ejcn.1601993
   PubMed Web of Science ®Google Scholar
• Habib SS. Body mass index and body fat percentage in assessment of obesity prevalence in Saudi adults. Biomed Environ Sci. 2013;26:94–99. doi:10.3967/0895-3988.2013.02.003
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
   PubMed Web of Science ®Google Scholar
• Salgado AL, Carvalho L, Oliveira AC, Santos VN, Vieira JG, Parise ER. Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. Arq Gastroenterol. 2010;47(2):165–169. doi:10.1590/S0004-28032010000200009
   PubMedGoogle Scholar
• Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the national health and nutrition examination survey III. PLoS One. 2010;5(5):e10805. doi:10.1371/journal.pone.0010805
   PubMed Web of Science ®Google Scholar
• Maliszewska K, Adamska-Patruno E, Krętowski A. The interplay between muscle mass decline, obesity, and type 2 diabetes. Pol Arch Intern Med. 2019;129(11):809–816. doi:10.20452/pamw.15025.
   PubMedGoogle Scholar
• Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes. 2019;12:1057–1072. doi:10.2147/DMSO.S186600
   PubMed Web of Science ®Google Scholar
• Kim TN, Choi KM. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. J Cell Biochem. 2015;116(7):1171–1178. doi:10.1002/jcb.25077
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Margioris AN. Sarcopenic obesity. Hormones. 2018;17(3):321–331. doi:10.1007/s42000-018-0049-x
   PubMedGoogle Scholar
• Nader GA, Esser KA. Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol. 2001;90:1936–1942. doi:10.1152/jappl.2001.90.5.1936
   PubMed Web of Science ®Google Scholar
• Doherty TJ. Invited review: aging and sarcopenia. J Appl Physiol. 2003;95:1717–1727. doi:10.1152/japplphysiol.00347.2003
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism. 2000;49:467–472. doi:10.1016/S0026-0495(00)80010-4
   PubMed Web of Science ®Google Scholar
• Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140–1142. doi:10.1126/science.1082889
   PubMed Web of Science ®Google Scholar
• Habib SS, Al Regaiey KA, Al Dokhi L. Assessment of adipokines relationships with cardiovascular risk markers in relation to body indices in normoglycemic males. Pak J Med Sci. 2013;29(1):21–26. doi:10.12669/pjms.291.2913
   PubMed Web of Science ®Google Scholar
• Habib SS. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition. Saudi Med J. 2012;33(5):495–499.
   PubMedGoogle Scholar
• Shou J, Chen PJ, Xiao WH. Mechanism of increased risk of insulin resistance in aging skeletal muscle. Diabetol Metab Syndr. 2020;11(12):14. doi:10.1186/s13098-020-0523-x
   Google Scholar
• Seo YG, Song HJ, Song YR. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. J Cachexia Sarcopenia Muscle. 2020;11(3):710–725. doi:10.1002/jcsm.12548.
   PubMed Web of Science ®Google Scholar
• Bjørnsen T, Wernbom M, Kirketeig A, et al. Type 1 muscle fiber hypertrophy after blood flow-restricted training in powerlifters. Med Sci Sports Exerc. 2019;51(2):288–298. doi:10.1249/MSS.0000000000001775
   PubMed Web of Science ®Google Scholar
• Sieljacks P, Wang J, Groennebaek T, et al. Six weeks of low-load blood flow restricted and high-load resistance exercise training produce similar increases in cumulative myofibrillar protein synthesis and ribosomal biogenesis in healthy males. Front Physiol. 2019;29(10):649. doi:10.3389/fphys.2019.00649
   Google Scholar
• Chen ME, Chandramouli AG, Considine RV, Hannon TS, Mather KJ. Comparison of β-cell function between overweight/obese adults and adolescents across the spectrum of glycemia. Diabetes Care. 2018;41(2):318–325. doi:10.2337/dc17-1373
   PubMedGoogle Scholar
• Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr. 2013;56(1):270–278. doi:10.1016/j.archger.2012.09.007
   PubMed Web of Science ®Google Scholar
• Kim JH, Cho JJ, Park YS. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci. 2015;30(3):264–271. doi:10.3346/jkms.2015.30.3.264
   PubMed Web of Science ®Google Scholar
• Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017;35:200–221. doi:10.1016/j.arr.2016.09.008
   PubMed Web of Science ®Google Scholar
• Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi:10.1186/s12933-018-0762-4
   PubMed Web of Science ®Google Scholar
• Lin D, Qi Y, Huang C, et al. Associations of lipid parameters with insulin resistance and diabetes: a population-based study. Clin Nutr. 2018;37(4):1423–1429. doi:10.1016/j.clnu.2017.06.018
   PubMed Web of Science ®Google Scholar